SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 73 filers reported holding SAVARA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $135,759 | +24.8% | 35,915 | +5.5% | 0.00% | – |
Q2 2023 | $108,815 | +34.3% | 34,058 | +13.6% | 0.00% | – |
Q2 2020 | $81,000 | +55.8% | 29,981 | +22.7% | 0.00% | – |
Q1 2020 | $52,000 | -38.8% | 24,431 | +111.5% | 0.00% | – |
Q1 2019 | $85,000 | +9.0% | 11,550 | +12.5% | 0.00% | – |
Q4 2018 | $78,000 | -40.0% | 10,271 | -12.0% | 0.00% | – |
Q3 2018 | $130,000 | -43.5% | 11,678 | -42.8% | 0.00% | – |
Q2 2018 | $230,000 | +2455.6% | 20,402 | +2079.7% | 0.00% | – |
Q1 2018 | $9,000 | -25.0% | 936 | +13.2% | 0.00% | – |
Q4 2017 | $12,000 | – | 827 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 3,313,602 | $12,525,416 | 47.59% |
NEA Management Company, LLC | 24,471,264 | $92,501,378 | 7.14% |
Bain Capital Life Sciences Investors, LLC | 14,232,751 | $53,799,799 | 6.02% |
TCG Crossover Management, LLC | 10,000,000 | $37,800,000 | 5.57% |
VR Adviser, LLC | 7,184,865 | $27,158,790 | 2.86% |
Affinity Asset Advisors, LLC | 1,150,000 | $4,347,000 | 1.22% |
Sio Capital Management, LLC | 896,250 | $3,387,825 | 1.05% |
Frazier Life Sciences Management, L.P. | 4,000,000 | $15,120,000 | 1.00% |
Vivo Capital, LLC | 1,913,349 | $7,232,459 | 0.79% |
Nantahala Capital Management | 1,039,364 | $3,928,796 | 0.34% |